Timely assessment of 5-year relative survival for patients with thyroid cancer from Taizhou, eastern China: a period analysis.

IF 2.1 4区 医学 Q3 ONCOLOGY European Journal of Cancer Prevention Pub Date : 2024-01-01 Epub Date: 2023-07-19 DOI:10.1097/CEJ.0000000000000830
Jiajia Huang, Jun Cao, Luyao Zhang, Meiyu Fang, Yongran Cheng, Da-Lin Lu, Liangyou Wang, Tianhui Chen
{"title":"Timely assessment of 5-year relative survival for patients with thyroid cancer from Taizhou, eastern China: a period analysis.","authors":"Jiajia Huang, Jun Cao, Luyao Zhang, Meiyu Fang, Yongran Cheng, Da-Lin Lu, Liangyou Wang, Tianhui Chen","doi":"10.1097/CEJ.0000000000000830","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While timely assessment of long-term survival in thyroid cancer patients is critical for assessing early detection and screening programs for thyroid cancer, those data are sorely lacking in China. We aimed to timely and accurately assess the long-term survival of thyroid cancer patients in eastern China.</p><p><strong>Methods: </strong>Patients diagnosed with thyroid cancer during 2004-2018 from four cancer registries in Taizhou, eastern China were included. The 5-year relative survival was estimated by period analysis and stratified by sex, age at diagnosis, and region. The 5-year RS of thyroid cancer patients during 2019-2023 was also predicted using the model-based period analysis.</p><p><strong>Results: </strong>During 2014-2018, the overall 5-year relative survival of thyroid cancer patients was 87.7%, 91.2% for women and 79.4% for men. The 5-year RS decreased along with increasing age at diagnosis, decreasing from 94.9% for age <45 years to 81.3% for age >74 years, while 5-year RS was higher in urban areas than in rural areas (93.2% vs. 86.1%). The 5-year RS for thyroid cancer patients improved greatly between 2004-2008 to 2014-2018. The predicted overall 5-year RS could reach 91.4% over the upcoming 2019-2023 period.</p><p><strong>Conclusion: </strong>We provided, for the first time in China using period analysis, the most up-to-date 5-year RS for thyroid cancer patients from Taizhou, eastern China, which has important implications for timely evaluation on early detection and screening programs for patients with thyroid cancer in eastern China.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"62-68"},"PeriodicalIF":2.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer Prevention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CEJ.0000000000000830","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: While timely assessment of long-term survival in thyroid cancer patients is critical for assessing early detection and screening programs for thyroid cancer, those data are sorely lacking in China. We aimed to timely and accurately assess the long-term survival of thyroid cancer patients in eastern China.

Methods: Patients diagnosed with thyroid cancer during 2004-2018 from four cancer registries in Taizhou, eastern China were included. The 5-year relative survival was estimated by period analysis and stratified by sex, age at diagnosis, and region. The 5-year RS of thyroid cancer patients during 2019-2023 was also predicted using the model-based period analysis.

Results: During 2014-2018, the overall 5-year relative survival of thyroid cancer patients was 87.7%, 91.2% for women and 79.4% for men. The 5-year RS decreased along with increasing age at diagnosis, decreasing from 94.9% for age <45 years to 81.3% for age >74 years, while 5-year RS was higher in urban areas than in rural areas (93.2% vs. 86.1%). The 5-year RS for thyroid cancer patients improved greatly between 2004-2008 to 2014-2018. The predicted overall 5-year RS could reach 91.4% over the upcoming 2019-2023 period.

Conclusion: We provided, for the first time in China using period analysis, the most up-to-date 5-year RS for thyroid cancer patients from Taizhou, eastern China, which has important implications for timely evaluation on early detection and screening programs for patients with thyroid cancer in eastern China.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中国东部台州甲状腺癌患者5年相对生存率的及时评估:周期分析。
背景:及时评估甲状腺癌患者的长期生存率对于评估甲状腺癌的早期检测和筛查项目至关重要,但在中国,这些数据非常缺乏。我们旨在及时、准确地评估中国东部地区甲状腺癌患者的长期生存情况:方法:纳入华东地区台州市四个癌症登记中心 2004-2018 年间确诊的甲状腺癌患者。采用周期分析法估算5年相对生存率,并按性别、诊断年龄和地区进行分层。此外,还利用基于模型的时期分析预测了2019-2023年甲状腺癌患者的5年RS:结果:2014-2018年间,甲状腺癌患者的总体5年相对生存率为87.7%,其中女性为91.2%,男性为79.4%。5年相对生存率随着诊断年龄的增加而下降,从74岁的94.9%下降到74岁的94.9%,而城市地区的5年相对生存率高于农村地区(93.2%对86.1%)。从2004-2008年到2014-2018年,甲状腺癌患者的5年RS有了很大改善。据预测,在即将到来的2019-2023年期间,总体5年RS可达到91.4%:我们在国内首次采用周期分析法提供了华东地区台州甲状腺癌患者的最新5年RS,这对及时评估华东地区甲状腺癌患者的早期发现和筛查项目具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
4.20%
发文量
96
审稿时长
1 months
期刊介绍: European Journal of Cancer Prevention aims to promote an increased awareness of all aspects of cancer prevention and to stimulate new ideas and innovations. The Journal has a wide-ranging scope, covering such aspects as descriptive and metabolic epidemiology, histopathology, genetics, biochemistry, molecular biology, microbiology, clinical medicine, intervention trials and public education, basic laboratory studies and special group studies. Although affiliated to a European organization, the journal addresses issues of international importance.
期刊最新文献
Marital status as an independent prognostic factor for survival in women with vaginal cancer: evidence from the SEER database analysis. Use of stool DNA for colorectal cancer screening: a meta-analysis and systematic review. Long-term trends in the burden of breast cancer in China over three decades: a joinpoint regression and age-period-cohort analysis based on Global Burden of Disease 2021. Cryoablation of early breast cancer: the challenge towards de-escalation of surgical treatment. Clinical significance of atypical glandular cells on cytology: 10 years' experience of a colposcopic referral center.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1